Nima Sharifi, MD, Cleveland Clinic Lerner Research Institute (IMAGE)

Cleveland Clinic

Nima Sharifi, MD, Cleveland Clinic Lerner Research Institute

Caption

In a new study led by Dr. Nima Sharifi of Cleveland Clinic, researchers show that a testosterone-related genetic variant - HSD3B1(1245C) - is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer.

Credit

Cleveland Clinic

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.